Overview
This page compares Arbitrum and Injective with live PEPS metrics. Rankings (#95 vs #99) and liquidity profiles differ, so traders often use them for distinct roles rather than as perfect substitutes.
Quick winners
Full comparison
| Metric | ARB | INJ |
|---|---|---|
| Price | $0.081300 | $5.08 |
| Market Cap | $543.44M | $490.41M |
| FDV | — | — |
| Volume 24h | $4.58M | $2.27M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 95.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.47% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | ARB | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +3.83% | +4.65% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | ARB | INJ |
|---|---|---|
| RSI | 42.16 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.00 | 0.29 |
| ADX | 22.88 | 12.19 |
| Support | 0.08 | 4.91 |
| Resistance | 0.09 | 5.47 |
| Trend | bearish | neutral |
| Momentum | — | — |
| Signal | neutral | neutral |
Automatic technical analysis
Use the indicator table as a checklist: if momentum and trend align on one asset while the other diverges, relative-value setups become more interesting — still without certainty.
Fundamentals
| Metric | ARB | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 4.00 | 0.00 |
| Github activity | 101.00 | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Arbitrum
Injective
Pros and cons
Pros of Arbitrum
- Market-cap scale on Arbitrum may dampen some idiosyncratic shocks versus smaller peers.
- Arbitrum has an established coin page footprint on PEPS for continuous monitoring.
- Arbitrum typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
Cons of Arbitrum
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Indicator stacks on Arbitrum may stay stretched longer than expected in strong trends.
- When dominance narratives fade, Arbitrum can lag hotter rotation names.
Pros of Injective
- PEPS tracking for Injective still includes AI score and level context for monitoring.
- Injective can offer higher relative beta when market attention rotates toward its niche.
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- If technical momentum aligns, Injective may outperform on medium-term windows.
Cons of Injective
- Relative underperformance versus Arbitrum can persist through entire market regimes.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Trend failures on Injective often travel faster than on more established assets.
Which looks stronger right now?
Statistically, higher market cap (Arbitrum) often correlates with deeper books, while hotter 24h prints (Injective) can fade. Position sizing should reflect that uncertainty.
AI summary
In about three hundred words of context: Arbitrum (ARB) trades near $0.081300 with a +3.83% day move, while Injective (INJ) is around $5.08 (+4.65%). Volume leadership currently sits with Arbitrum, and market-cap leadership with Arbitrum. Technical trend labels read bearish vs neutral, with RSI near 42.16/49.29. Bottom line: use this page as a structured checklist, then open each coin page and related PEPS tools before acting. Nothing here is financial advice.
FAQ
Which is better, Arbitrum or Injective?
“Better” depends on horizon and risk. Arbitrum leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, ARB or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Arbitrum and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Arbitrum currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.